118 related articles for article (PubMed ID: 25381261)
1. Darinaparsin inhibits prostate tumor-initiating cells and Du145 xenografts and is an inhibitor of hedgehog signaling.
Bansal N; Farley NJ; Wu L; Lewis J; Youssoufian H; Bertino JR
Mol Cancer Ther; 2015 Jan; 14(1):23-30. PubMed ID: 25381261
[TBL] [Abstract][Full Text] [Related]
2. The novel organic arsenical darinaparsin induces MAPK-mediated and SHP1-dependent cell death in T-cell lymphoma and Hodgkin lymphoma cells and human xenograft models.
Ravi D; Bhalla S; Gartenhaus RB; Crombie J; Kandela I; Sharma J; Mazar A; Evens AM
Clin Cancer Res; 2014 Dec; 20(23):6023-33. PubMed ID: 25316819
[TBL] [Abstract][Full Text] [Related]
3. Darinaparsin induces a unique cellular response and is active in an arsenic trioxide-resistant myeloma cell line.
Matulis SM; Morales AA; Yehiayan L; Croutch C; Gutman D; Cai Y; Lee KP; Boise LH
Mol Cancer Ther; 2009 May; 8(5):1197-206. PubMed ID: 19417148
[TBL] [Abstract][Full Text] [Related]
4. Arsenic trioxide inhibits Hedgehog, Notch and stem cell properties in glioblastoma neurospheres.
Ding D; Lim KS; Eberhart CG
Acta Neuropathol Commun; 2014 Mar; 2():31. PubMed ID: 24685274
[TBL] [Abstract][Full Text] [Related]
5. High expression of TROP2 characterizes different cell subpopulations in androgen-sensitive and androgen-independent prostate cancer cells.
Xie J; Mølck C; Paquet-Fifield S; Butler L; ; Sloan E; Ventura S; Hollande F
Oncotarget; 2016 Jul; 7(28):44492-44504. PubMed ID: 27283984
[TBL] [Abstract][Full Text] [Related]
6. Everolimus (RAD001) sensitizes prostate cancer cells to docetaxel by down-regulation of HIF-1α and sphingosine kinase 1.
Alshaker H; Wang Q; Kawano Y; Arafat T; Böhler T; Winkler M; Cooper C; Pchejetski D
Oncotarget; 2016 Dec; 7(49):80943-80956. PubMed ID: 27821815
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological GLI2 inhibition prevents myofibroblast cell-cycle progression and reduces kidney fibrosis.
Kramann R; Fleig SV; Schneider RK; Fabian SL; DiRocco DP; Maarouf O; Wongboonsin J; Ikeda Y; Heckl D; Chang SL; Rennke HG; Waikar SS; Humphreys BD
J Clin Invest; 2015 Aug; 125(8):2935-51. PubMed ID: 26193634
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of STAT3 signaling targets both tumor-initiating and differentiated cell populations in prostate cancer.
Han Z; Wang X; Ma L; Chen L; Xiao M; Huang L; Cao Y; Bai J; Ma D; Zhou J; Hong Z
Oncotarget; 2014 Sep; 5(18):8416-28. PubMed ID: 25261365
[TBL] [Abstract][Full Text] [Related]
9. A novel arsenical has antitumor activity toward As2O3-resistant and MRP1/ABCC1-overexpressing cell lines.
Diaz Z; Mann KK; Marcoux S; Kourelis M; Colombo M; Komarnitsky PB; Miller WH
Leukemia; 2008 Oct; 22(10):1853-63. PubMed ID: 18633430
[TBL] [Abstract][Full Text] [Related]
10. Anti-cancer efficacy of SREBP inhibitor, alone or in combination with docetaxel, in prostate cancer harboring p53 mutations.
Li X; Wu JB; Chung LW; Huang WC
Oncotarget; 2015 Dec; 6(38):41018-32. PubMed ID: 26512780
[TBL] [Abstract][Full Text] [Related]
11. Darinaparsin: a novel organic arsenical with promising anticancer activity.
Mann KK; Wallner B; Lossos IS; Miller WH
Expert Opin Investig Drugs; 2009 Nov; 18(11):1727-34. PubMed ID: 19780704
[TBL] [Abstract][Full Text] [Related]
12. The Hedgehog signalling pathway mediates drug response of MCF-7 mammosphere cells in breast cancer patients.
He M; Fu Y; Yan Y; Xiao Q; Wu H; Yao W; Zhao H; Zhao L; Jiang Q; Yu Z; Jin F; Mi X; Wang E; Cui Z; Fu L; Chen J; Wei M
Clin Sci (Lond); 2015 Nov; 129(9):809-22. PubMed ID: 26201092
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of PI3Kβ signaling with AZD8186 inhibits growth of PTEN-deficient breast and prostate tumors alone and in combination with docetaxel.
Hancox U; Cosulich S; Hanson L; Trigwell C; Lenaghan C; Ellston R; Dry H; Crafter C; Barlaam B; Fitzek M; Smith PD; Ogilvie D; D'Cruz C; Castriotta L; Wedge SR; Ward L; Powell S; Lawson M; Davies BR; Harrington EA; Foster E; Cumberbatch M; Green S; Barry ST
Mol Cancer Ther; 2015 Jan; 14(1):48-58. PubMed ID: 25398829
[TBL] [Abstract][Full Text] [Related]
14. Hedgehog pathway dysregulation contributes to the pathogenesis of human gastrointestinal stromal tumors via GLI-mediated activation of KIT expression.
Tang CM; Lee TE; Syed SA; Burgoyne AM; Leonard SY; Gao F; Chan JC; Shi E; Chmielecki J; Morosini D; Wang K; Ross JS; Kendrick ML; Bardsley MR; Siena M; Mao J; Harismendy O; Ordog T; Sicklick JK
Oncotarget; 2016 Nov; 7(48):78226-78241. PubMed ID: 27793025
[TBL] [Abstract][Full Text] [Related]
15. Sabutoclax, a Mcl-1 antagonist, inhibits tumorigenesis in transgenic mouse and human xenograft models of prostate cancer.
Jackson RS; Placzek W; Fernandez A; Ziaee S; Chu CY; Wei J; Stebbins J; Kitada S; Fritz G; Reed JC; Chung LW; Pellecchia M; Bhowmick NA
Neoplasia; 2012 Jul; 14(7):656-65. PubMed ID: 22904682
[TBL] [Abstract][Full Text] [Related]
16. Role of GLI2 transcription factor in growth and tumorigenicity of prostate cells.
Thiyagarajan S; Bhatia N; Reagan-Shaw S; Cozma D; Thomas-Tikhonenko A; Ahmad N; Spiegelman VS
Cancer Res; 2007 Nov; 67(22):10642-6. PubMed ID: 18006803
[TBL] [Abstract][Full Text] [Related]
17. Suppression of acquired docetaxel resistance in prostate cancer through depletion of notch- and hedgehog-dependent tumor-initiating cells.
Domingo-Domenech J; Vidal SJ; Rodriguez-Bravo V; Castillo-Martin M; Quinn SA; Rodriguez-Barrueco R; Bonal DM; Charytonowicz E; Gladoun N; de la Iglesia-Vicente J; Petrylak DP; Benson MC; Silva JM; Cordon-Cardo C
Cancer Cell; 2012 Sep; 22(3):373-88. PubMed ID: 22975379
[TBL] [Abstract][Full Text] [Related]
18. HIV-1 protease inhibitor, ritonavir: a potent inhibitor of CYP3A4, enhanced the anticancer effects of docetaxel in androgen-independent prostate cancer cells in vitro and in vivo.
Ikezoe T; Hisatake Y; Takeuchi T; Ohtsuki Y; Yang Y; Said JW; Taguchi H; Koeffler HP
Cancer Res; 2004 Oct; 64(20):7426-31. PubMed ID: 15492266
[TBL] [Abstract][Full Text] [Related]
19. Combined targeting of epidermal growth factor receptor and hedgehog signaling by gefitinib and cyclopamine cooperatively improves the cytotoxic effects of docetaxel on metastatic prostate cancer cells.
Mimeault M; Johansson SL; Vankatraman G; Moore E; Henichart JP; Depreux P; Lin MF; Batra SK
Mol Cancer Ther; 2007 Mar; 6(3):967-78. PubMed ID: 17363490
[TBL] [Abstract][Full Text] [Related]
20. Cyclin-dependent kinase inhibitor, P276-00, inhibits HIF-1α and induces G2/M arrest under hypoxia in prostate cancer cells.
Manohar SM; Padgaonkar AA; Jalota-Badhwar A; Rao SV; Joshi KS
Prostate Cancer Prostatic Dis; 2012 Mar; 15(1):15-27. PubMed ID: 22083267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
